Home / Funds / GSA Capital Partners LLP
GSA Capital Partners LLP
The short positions this fund discloses today, across every market.
21 open positions
6 Markets
August 12, 2026 Last disclosure
213800CWAHHW6YYZII58 LEI
| Issuer | Market | % of capital | Since |
|---|---|---|---|
| Nyesa Valores Corporacion, S.A. | Spain | 1.56% | August 11, 2026 |
| Tessellis SPA | Italy | 1.38% | August 12, 2026 |
| Tobii AB | Sweden | 1.31% | July 17, 2026 |
| Oncopeptides AB | Sweden | 1.30% | August 11, 2026 |
| Valneva SE | France | 1.21% | July 21, 2026 |
| Hexagon Composites | Norway | 1.19% | August 7, 2026 |
| Powercell Sweden AB (publ) | Sweden | 0.91% | July 9, 2026 |
| RaySearch Laboratories AB (publ) | Sweden | 0.89% | August 11, 2026 |
| OssDsign AB | Sweden | 0.81% | June 1, 2026 |
| Hilbert Group AB (publ) | Sweden | 0.79% | August 6, 2026 |
| Hansa Biopharma AB | Sweden | 0.60% | August 6, 2026 |
| Solutions 30 SE | France | 0.60% | July 22, 2026 |
| Bertrandt Aktiengesellschaft | Germany | 0.53% | September 28, 2017 |
| S&T AG | Germany | 0.52% | November 14, 2017 |
| ADVA Optical Networking SE | Germany | 0.50% | October 26, 2017 |
| Cellectis | France | 0.50% | February 7, 2023 |
| Hamborner Reit AG | Germany | 0.50% | October 13, 2017 |
| Nobia AB | Sweden | 0.50% | June 12, 2026 |
| Thor Medical ASA | Norway | 0.50% | June 24, 2026 |
| Trevi - Finanziaria Industriale SPA | Italy | 0.50% | August 11, 2026 |
| Tubacex, S.A. | Spain | 0.50% | July 10, 2026 |
History of disclosures
| Date | Issuer | Market | % of capital | End of publication |
|---|---|---|---|---|
| August 12, 2026 | Tessellis SPA | Italy | 1.38% | still open |
| August 11, 2026 | Nyesa Valores Corporacion, S.A. | Spain | 1.56% | still open |
| August 11, 2026 | 2020 Bulkers | Norway | 1.38% | August 12, 2026 |
| August 11, 2026 | Oncopeptides AB | Sweden | 1.30% | still open |
| August 11, 2026 | RaySearch Laboratories AB (publ) | Sweden | 0.89% | still open |
| August 11, 2026 | Trevi - Finanziaria Industriale SPA | Italy | 0.50% | still open |
| August 10, 2026 | RaySearch Laboratories AB (publ) | Sweden | 0.90% | still open |
| August 7, 2026 | 2020 Bulkers | Norway | 1.47% | August 11, 2026 |
| August 7, 2026 | Hexagon Composites | Norway | 1.19% | still open |
| August 6, 2026 | Hexagon Composites | Norway | 1.22% | August 7, 2026 |
| August 6, 2026 | Hilbert Group AB (publ) | Sweden | 0.79% | still open |
| August 6, 2026 | Hansa Biopharma AB | Sweden | 0.60% | still open |
| August 5, 2026 | 2020 Bulkers | Norway | 1.65% | August 7, 2026 |
| August 5, 2026 | Nyesa Valores Corporacion, S.A. | Spain | 1.64% | still open |
| August 4, 2026 | 2020 Bulkers | Norway | 1.74% | August 5, 2026 |
| August 4, 2026 | Ekinops | France | 0.49% | August 6, 2026 |
| August 3, 2026 | 2020 Bulkers | Norway | 1.80% | August 4, 2026 |
| July 31, 2026 | 2020 Bulkers | Norway | 1.92% | August 3, 2026 |
| July 30, 2026 | 2020 Bulkers | Norway | 2.07% | July 31, 2026 |
| July 30, 2026 | Nyesa Valores Corporacion, S.A. | Spain | 1.57% | still open |
| July 30, 2026 | Hexagon Composites | Norway | 1.38% | July 31, 2026 |
| July 29, 2026 | 2020 Bulkers | Norway | 2.23% | July 30, 2026 |
| July 29, 2026 | RaySearch Laboratories AB (publ) | Sweden | 0.87% | still open |
| July 28, 2026 | 2020 Bulkers | Norway | 2.36% | July 29, 2026 |
| July 28, 2026 | Hexagon Composites | Norway | 1.46% | July 29, 2026 |
| July 28, 2026 | Oncopeptides AB | Sweden | 1.21% | still open |
| July 27, 2026 | 2020 Bulkers | Norway | 2.43% | July 28, 2026 |
| July 24, 2026 | 2020 Bulkers | Norway | 2.55% | July 27, 2026 |
| July 23, 2026 | 2020 Bulkers | Norway | 2.84% | July 24, 2026 |
| July 22, 2026 | 2020 Bulkers | Norway | 2.91% | July 23, 2026 |
| July 22, 2026 | Oncopeptides AB | Sweden | 1.11% | still open |
| July 22, 2026 | Solutions 30 SE | France | 0.60% | still open |
| July 21, 2026 | 2020 Bulkers | Norway | 3.01% | July 22, 2026 |
| July 21, 2026 | Valneva SE | France | 1.21% | still open |
| July 17, 2026 | 2020 Bulkers | Norway | 3.14% | July 20, 2026 |
| July 17, 2026 | Tobii AB | Sweden | 1.31% | still open |
| July 16, 2026 | Oncopeptides AB | Sweden | 1.03% | still open |
| July 16, 2026 | RaySearch Laboratories AB (publ) | Sweden | 0.79% | still open |
| July 15, 2026 | 2020 Bulkers | Norway | 3.29% | July 16, 2026 |
| July 14, 2026 | 2020 Bulkers | Norway | 3.37% | July 15, 2026 |
| July 13, 2026 | 2020 Bulkers | Norway | 3.49% | July 14, 2026 |
| July 10, 2026 | 2020 Bulkers | Norway | 3.59% | July 13, 2026 |
| July 10, 2026 | Oncopeptides AB | Sweden | 0.92% | still open |
| July 10, 2026 | Tubacex, S.A. | Spain | 0.50% | still open |
| July 9, 2026 | Powercell Sweden AB (publ) | Sweden | 0.91% | still open |
| July 7, 2026 | 2020 Bulkers | Norway | 3.65% | July 9, 2026 |
| July 7, 2026 | Hexagon Composites | Norway | 1.58% | July 10, 2026 |
| July 7, 2026 | Valneva SE | France | 1.10% | still open |
| July 7, 2026 | Hansa Biopharma AB | Sweden | 0.59% | still open |
| July 3, 2026 | Oncopeptides AB | Sweden | 0.81% | still open |
The funds short on the same companies
- Citadel Advisors LLC 4 companies in common
- Connor, Clark & Lunn Investment Management LTD. 3 companies in common
- ActusRayPartners Limited 2 companies in common
- Arrowstreet Capital Limited Partnership 1 company in common
- Citadel Securities (Europe) Limited 1 company in common
- D E Shaw Co LP 1 company in common
- D. E. Shaw & CO., L.P. 1 company in common
- JPMorgan Asset Management (UK) Ltd 1 company in common
- Marble Bar Asset Management LLP 1 company in common
- Origo Fonder AB 1 company in common
- PDT Partners, LLC 1 company in common
- Qube Research & Technologies Limited 1 company in common
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, GSA Capital Partners LLP, data as at August 12, 2026, https://www.quivad.com/detenteur/gsa-capital-partners-llp